Furthermore, SHMT2 has been reported to be up-regulated and overexpressed in the cancer cells and a potential cancer driver gene [18–20], and low expression of SHMT2 was shown to be closely related to 5-FU resistance in CRC [21]. The gene discussed is SHMT2; the disease is cancer.